Indefinite Delivery Contract 75N95025D00005
Award Date
3/14/23
Last Date to Order
3/13/28
Federal Agency
National Institute on Drug Abuse
Awardee
Infinity Biologix LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $15 million Indefinite Delivery Contract (IDC) to Rutgers, The State University to operate the NIDA Center for Genetic Studies. This single-award contract has a 5-year period of performance through March 2028. Under this IDC, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Emmes Company LLC, a for-profit limited liability company, to serve as the NIDA Data, Statistics, and Clinical Trial Support Center. Under this single-award IDIQ contract valued up to $31.2 million over a five-year period from September 2022 to September 2027, The...
The National Institute on Drug Abuse awarded Rutgers, The State University a single-award Indefinite Delivery Contract to establish and operate the NIDA Center for Genetic Studies. The contract has a potential value of $19.7 million over a five-year base period from September 2018 to September 2022. Rutgers has received multiple firm fixed price task orders against the contract to provide research services in support of the Center, including receiving, processing, storing, and distributing...
The National Institutes of Health's National Institute on Drug Abuse (NIDA) awarded a $149 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the New York Genome Center, Inc. (doing business as Nygc) to provide sequencing services for the BRAIN Initiative Cell Atlas Network (BICAN). Under this master IDIQ, NIDA has issued two task orders to Nygc totaling over $110 million for brain cell sequencing work. The first $73.8 million task order is for unspecified BICAN sequencing...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to Actuated Medical, Inc., doing business as Piezo Resonance Innovations Inc. The $35 million, single-award IDC runs through September 2028 and is for research and development services related to biocompatibility testing, animal studies, and sterilization testing in support of NIDA's Blueprint MedTech (BPMT) Initiative. This work involves...
The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...
This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a $49,500,000 ceiling value to The Emmes Company LLC, a for-profit limited liability company, to serve as the Clinical Coordinating Center for NIDA's Clinical Trials Network (CTN). The contract has a period of performance from August 15, 2024 to August 14, 2029. Under this IDC, NIDA has issued three task orders to date,...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) awarded an Indefinite Delivery Contract (IDC) to The Bizzell Group LLC, a U.S. Small Business Administration (SBA) certified HUBZone and minority-owned firm. The contract, valued at up to $1,000,000, provides logistics, communications, and clinical study auxiliary support services to NIDA's Division of Therapeutics and Medical Consequences from May 2021 through April 2026. To...
The National Institute on Drug Abuse (NIDA) awarded Booz Allen Hamilton Inc. a $47,000,000 single-award Indefinite Delivery Contract to establish and maintain the NIDA Developmental Studies Biorepository and Analysis Center. This center will support the Adolescent Brain Cognitive Development (ABCD) Study and HEALthy Brain and Child Development (HBCD) Study by receiving, processing, storing, and distributing biospecimen samples in a CLIA-certified laboratory. Booz Allen Hamilton will provide...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 75N95025D00005-75N95025F00001 | Infinity Biologix LLC | $2.7m | 3/14/25 | 3/13/26 | 3/12/25 |